|
Sign In to gain access to subscriptions and/or personal tools.
|
Screening for Colorectal Cancer in Elderly Persons: Who Should We Screen and When Can We Stop?
Shail Maheshwari, MD1,
Tushar Patel, MbChB2*,
and
Parita Patel, MD3
1 Department of Medicine, Baylor College of Medicine
2 Department of Internal Medicine, Ohio State University Medical Center
3 Department of Family Medicine, Ohio State University Medical Center
* To whom correspondence should be addressed. E-mail: tushar.patel{at}osumc.edu.
 |
Abstract |
|---|
Objective: The aim of this study was to quantify the impact of age on the potential benefits of screening for colorectal cancer. Method: Life-table analysis of the risks of dying from colorectal cancer or from all other causes was performed. The impact of prematurely stopping screening was compared to the maximal potential benefit expected from lifelong screening. Results: The relative proportion of deaths from colorectal cancer compared to all other causes was greatest at the age of 62 and diminished thereafter. A total of 80% of the maximal benefit from screening was achieved by screening till the age of 82. The impact of prematurely stopping screening varied with gender and race. Discussion: The maximal societal benefit will be achieved by screening at younger ages because of competing causes of mortality among older people. Gender and ethnicity should be considered in individual decisions to stop screening at a given age.
First published on December 18, 2007, doi:10.1177/0898264307309939
Journal of Aging and Health 2008;20:126.
A more recent version of this article appeared on February 1, 2008

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|